{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:28:03Z","timestamp":1793363283055,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100019258","name":"Vingroup Joint Stock Company","doi-asserted-by":"crossref","award":["ISC.19.50"],"award-info":[{"award-number":["ISC.19.50"]}],"id":[{"id":"10.13039\/100019258","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04404-4","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T01:13:45Z","timestamp":1748567625000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Outcomes of autologous bone marrow mononuclear cell administration combined with educational intervention in the treatment of autism spectrum disorder: a randomized, open-label, controlled phase II clinical trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Liem Thanh","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong Mai","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang-Phuong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hau Thi","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan Thi Mai","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh","family":"Van Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Khanh","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao Thi Phuong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh Thi Phuong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van Thi","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoa Thi Phuong","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngan Kim","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doan","family":"Van Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"issue":"8","key":"4404_CR1","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/CHI.0b013e318179964f","volume":"47","author":"E Simonoff","year":"2008","unstructured":"Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry. 2008;47(8):921\u20139.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"4404_CR2","doi-asserted-by":"crossref","unstructured":"Baio J. Prevalence of autism spectrum disorder among children aged 8 years\u2014autism and developmental disabilities monitoring network, 11 sites, united States, 2014. MMWR Surveillance Summaries. 2018;67.","DOI":"10.15585\/mmwr.ss6706a1"},{"issue":"3","key":"4404_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1177\/1367493515598644","volume":"20","author":"M Kousha","year":"2016","unstructured":"Kousha M, Attar HA, Shoar Z. Anxiety, depression, and quality of life in Iranian mothers of children with autism spectrum disorder. J Child Health Care. 2016;20(3):405\u201314.","journal-title":"J Child Health Care"},{"key":"4404_CR4","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1007\/s10803-015-2521-7","volume":"45","author":"JP Leigh","year":"2015","unstructured":"Leigh JP, Du J. Brief report: forecasting the economic burden of autism in 2015 and 2025 in the united States. J Autism Dev Disord. 2015;45:4135\u20139.","journal-title":"J Autism Dev Disord"},{"issue":"5","key":"4404_CR5","first-page":"463","volume":"10","author":"AM Enstrom","year":"2009","unstructured":"Enstrom AM, Van de Water JA, Ashwood P. Autoimmunity in autism. Curr Opin Invest Drugs (London England: 2000). 2009;10(5):463.","journal-title":"Curr Opin Invest Drugs (London England: 2000)"},{"issue":"1","key":"4404_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.21307\/ane-2018-005","volume":"78","author":"G Bj\u00f8rklund","year":"2018","unstructured":"Bj\u00f8rklund G, Kern J, Urbina M, Saad K, El\u2013Houfey A, Geier D, et al. Cerebral hypoperfusion in autism spectrum disorder. Acta Neurobiol Exp. 2018;78(1):21\u20139.","journal-title":"Acta Neurobiol Exp"},{"issue":"1","key":"4404_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/brbi.1993.1010","volume":"7","author":"VK Singh","year":"1993","unstructured":"Singh VK, Warren RP, Odell JD, Warren WL, Cole P. Antibodies to Myelin basic protein in children with autistic behavior. Brain Behav Immun. 1993;7(1):97\u2013103.","journal-title":"Brain Behav Immun"},{"issue":"1\u20132","key":"4404_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0165-5728(96)00014-8","volume":"66","author":"VK Singh","year":"1996","unstructured":"Singh VK. Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J Neuroimmunol. 1996;66(1\u20132):143\u20135.","journal-title":"J Neuroimmunol"},{"key":"4404_CR9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s10875-004-6241-6","volume":"24","author":"P Ashwood","year":"2004","unstructured":"Ashwood P, Anthony A, Torrente F, Wakefield AJ. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and Gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol. 2004;24:664\u201373.","journal-title":"J Clin Immunol"},{"issue":"1\u20132","key":"4404_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jneuroim.2005.12.007","volume":"173","author":"P Ashwood","year":"2006","unstructured":"Ashwood P, Wakefield AJ. Immune activation of peripheral blood and mucosal CD3\u2009+\u2009lymphocyte cytokine profiles in children with autism and Gastrointestinal symptoms. J Neuroimmunol. 2006;173(1\u20132):126\u201334.","journal-title":"J Neuroimmunol"},{"issue":"40","key":"4404_CR11","doi-asserted-by":"publisher","first-page":"10695","DOI":"10.1523\/JNEUROSCI.2178-07.2007","volume":"27","author":"SE Smith","year":"2007","unstructured":"Smith SE, Li J, Garbett K, Mirnics K, Patterson PH. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci. 2007;27(40):10695\u2013702.","journal-title":"J Neurosci"},{"issue":"1","key":"4404_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ana.20315","volume":"57","author":"DL Vargas","year":"2005","unstructured":"Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals Neurology: Official J Am Neurol Association Child Neurol Soc. 2005;57(1):67\u201381.","journal-title":"Annals Neurology: Official J Am Neurol Association Child Neurol Soc"},{"issue":"1","key":"4404_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1196\/annals.1381.009","volume":"1107","author":"S Wills","year":"2007","unstructured":"Wills S, Cabanlit M, Bennett J, Ashwood P, Amaral D, Van De Water J. Autoantibodies in autism spectrum disorders (ASD). Ann N Y Acad Sci. 2007;1107(1):79\u201391.","journal-title":"Ann N Y Acad Sci"},{"issue":"1\u20132","key":"4404_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jneuroim.2007.11.004","volume":"194","author":"HS Singer","year":"2008","unstructured":"Singer HS, Morris CM, Gause CD, Gillin PK, Crawford S, Zimmerman AW. Antibodies against fetal brain in Sera of mothers with autistic children. J Neuroimmunol. 2008;194(1\u20132):165\u201372.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"4404_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1196\/annals.1381.010","volume":"1107","author":"M Cabanlit","year":"2007","unstructured":"Cabanlit M, Wills S, Goines P, Ashwood P, Van De Water J. Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann N Y Acad Sci. 2007;1107(1):92\u2013103.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"4404_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000119172","volume":"31","author":"RP Warren","year":"1995","unstructured":"Warren RP, Yonk J, Burger R, Odell D, Warren W. DR-positive T cells in autism: association with decreased plasma levels of the complement C4B protein. Neuropsychobiology. 1995;31(2):53\u20137.","journal-title":"Neuropsychobiology"},{"issue":"1","key":"4404_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1146\/annurev-genom-091212-153431","volume":"14","author":"G Huguet","year":"2013","unstructured":"Huguet G, Ey E, Bourgeron T. The genetic landscapes of autism spectrum disorders. Annu Rev Genom Hum Genet. 2013;14(1):191\u2013213.","journal-title":"Annu Rev Genom Hum Genet"},{"key":"4404_CR18","doi-asserted-by":"crossref","unstructured":"Hughes H, Moreno R, Ashwood P. Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD). Brain, behavior, and immunity. 2023;108:245\u2013\u200954.","DOI":"10.1016\/j.bbi.2022.12.001"},{"issue":"7526","key":"4404_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nature13772","volume":"515","author":"S De Rubeis","year":"2014","unstructured":"De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Ercument Cicek A, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014;515(7526):209\u201315.","journal-title":"Nature"},{"key":"4404_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fneur.2015.00081","volume":"6","author":"S Fumagalli","year":"2015","unstructured":"Fumagalli S, Perego C, Pischiutta F, Zanier ER, De Simoni M-G. The ischemic environment drives microglia and macrophage function. Front Neurol. 2015;6:81.","journal-title":"Front Neurol"},{"issue":"9","key":"4404_CR21","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/brain\/123.9.1838","volume":"123","author":"T Ohnishi","year":"2000","unstructured":"Ohnishi T, Matsuda H, Hashimoto T, Kunihiro T, Nishikawa M, Uema T, et al. Abnormal regional cerebral blood flow in childhood autism. Brain. 2000;123(9):1838\u201344.","journal-title":"Brain"},{"issue":"4","key":"4404_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1901\/jaba.1987.20-313","volume":"20","author":"DM Baer","year":"1987","unstructured":"Baer DM, Wolf MM, Risley TR. Some still-current dimensions of applied behavior analysis. J Appl Behav Anal. 1987;20(4):313\u201327.","journal-title":"J Appl Behav Anal"},{"issue":"1","key":"4404_CR23","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1542\/peds.2009-0958","volume":"125","author":"G Dawson","year":"2010","unstructured":"Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J, et al. Randomized, controlled trial of an intervention for toddlers with autism: the early start Denver model. Pediatrics. 2010;125(1):e17\u201323.","journal-title":"Pediatrics"},{"issue":"8","key":"4404_CR24","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.cpr.2013.07.005","volume":"33","author":"J Virues-Ortega","year":"2013","unstructured":"Virues-Ortega J, Julio FM, Pastor-Barriuso R. The TEACCH program for children and adults with autism: A meta-analysis of intervention studies. Clin Psychol Rev. 2013;33(8):940\u201353.","journal-title":"Clin Psychol Rev"},{"issue":"1","key":"4404_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/aur.1530","volume":"9","author":"H Segal-Gavish","year":"2016","unstructured":"Segal-Gavish H, Karvat G, Barak N, Barzilay R, Ganz J, Edry L, et al. Mesenchymal stem cell transplantation promotes neurogenesis and ameliorates autism related behaviors in BTBR mice. Autism Res. 2016;9(1):17\u201332.","journal-title":"Autism Res"},{"issue":"1","key":"4404_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11033-024-09292-0","volume":"51","author":"M Noshadian","year":"2024","unstructured":"Noshadian M, Ragerdi Kashani I, Asadi-Golshan R, Zarini D, Ghafari N, Zahedi E, et al. Benefits of bone marrow mesenchymal stem cells compared to their conditioned medium in valproic acid-induced autism in rats. Mol Biol Rep. 2024;51(1):353.","journal-title":"Mol Biol Rep"},{"key":"4404_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.bbr.2016.10.004","volume":"317","author":"S Ha","year":"2017","unstructured":"Ha S, Park H, Mahmood U, Ra JC, Suh YH, Chang KA. Human adipose-derived stem cells ameliorate repetitive behavior, social deficit and anxiety in a VPA-induced autism mouse model. Behav Brain Res. 2017;317:479\u201384.","journal-title":"Behav Brain Res"},{"key":"4404_CR28","doi-asserted-by":"crossref","unstructured":"Wong R. Neuroinflammation in autism spectrum disorders: potential target for mesenchymal stem cell-based therapy. Egypt J Neurol Psychiatry Neurosurg. 2022;58.","DOI":"10.1186\/s41983-022-00525-2"},{"issue":"1","key":"4404_CR29","first-page":"623875","volume":"2013","author":"A Sharma","year":"2013","unstructured":"Sharma A, Gokulchandran N, Sane H, Nagrajan A, Paranjape A, Kulkarni P, et al. Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study. Stem Cells Int. 2013;2013(1):623875.","journal-title":"Stem Cells Int"},{"key":"4404_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-11-196","volume":"11","author":"Y-T Lv","year":"2013","unstructured":"Lv Y-T, Zhang Y, Liu M, Qiuwaxi J, Cho SC, et al. Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. J Translational Med. 2013;11:1\u201310.","journal-title":"J Translational Med"},{"key":"4404_CR31","unstructured":"Bansal H, Singh L, Verma P, Agrawal A, Leon J, Sundell IB et al. A short study report on bone marrow aspirate concentrate cell therapy in ten South Asian Indian patients with autism. J Stem Cells. 2016;11(1)."},{"issue":"5","key":"4404_CR32","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/sctm.16-0474","volume":"6","author":"G Dawson","year":"2017","unstructured":"Dawson G, Sun JM, Davlantis KS, Murias M, Franz L, Troy J, et al. Autologous cord blood infusions are safe and feasible in young children with autism spectrum disorder: results of a single-center phase I open-label trial. Stem Cells Translational Med. 2017;6(5):1332\u20139.","journal-title":"Stem Cells Translational Med"},{"issue":"1","key":"4404_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/sctm.20-0102","volume":"10","author":"L Nguyen Thanh","year":"2021","unstructured":"Nguyen Thanh L, Nguyen H-P, Ngo MD, Bui VA, Dam PT, Bui HTP, et al. Outcomes of bone marrow mononuclear cell transplantation combined with interventional education for autism spectrum disorder. Stem Cells Translational Med. 2021;10(1):14\u201326.","journal-title":"Stem Cells Translational Med"},{"issue":"2","key":"4404_CR34","doi-asserted-by":"publisher","first-page":"e12445","DOI":"10.1111\/appy.12445","volume":"13","author":"N Sharifzadeh","year":"2021","unstructured":"Sharifzadeh N, Ghasemi A, Tavakol Afshari J, Moharari F, Soltanifar A, Talaei A, et al. Intrathecal autologous bone marrow stem cell therapy in children with autism: a randomized controlled trial. Asia-Pacific Psychiatry. 2021;13(2):e12445.","journal-title":"Asia-Pacific Psychiatry"},{"key":"4404_CR35","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jpeds.2020.03.011","volume":"222","author":"G Dawson","year":"2020","unstructured":"Dawson G, Sun JM, Baker J, Carpenter K, Compton S, Deaver M, et al. A phase II randomized clinical trial of the safety and efficacy of intravenous umbilical cord blood infusion for treatment of children with autism spectrum disorder. J Pediatr. 2020;222:164\u201373. e5.","journal-title":"J Pediatr"},{"key":"4404_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-017-1149-0","volume":"15","author":"X Liu","year":"2017","unstructured":"Liu X, Fu X, Dai G, Wang X, Zhang Z, Cheng H, et al. Comparative analysis of curative effect of bone marrow mesenchymal stem cell and bone marrow mononuclear cell transplantation for spastic cerebral palsy. J Translational Med. 2017;15:1\u20139.","journal-title":"J Translational Med"},{"issue":"21","key":"4404_CR37","first-page":"591","volume":"21","author":"F Edition","year":"2013","unstructured":"Edition F. Diagnostic and statistical manual of mental disorders. Am Psychiatric Assoc. 2013;21(21):591\u2013643.","journal-title":"Am Psychiatric Assoc"},{"key":"4404_CR38","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1007\/s10803-009-0704-9","volume":"39","author":"A Perry","year":"2009","unstructured":"Perry A, Flanagan HE, Dunn Geier J, Freeman NL. Brief report: the vineland adaptive behavior scales in young children with autism spectrum disorders at different cognitive levels. J Autism Dev Disord. 2009;39:1066\u201378.","journal-title":"J Autism Dev Disord"},{"key":"4404_CR39","doi-asserted-by":"publisher","unstructured":"Parkhurst J, Kawa JM. (2018). Childhood autism rating scales. In: Kreutzer JS, DeLuca J, Caplan B, editors. Encyclopedia of Clinical Neuropsychology. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-319-57111-9_1530.","DOI":"10.1007\/978-3-319-57111-9_1530"},{"issue":"7","key":"4404_CR40","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (edgmont). 2007;4(7):28.","journal-title":"Psychiatry (edgmont)"},{"key":"4404_CR41","unstructured":"Institute NC. Common terminology criteria for adverse events (CTCAE), version 4.03. National Cancer Institute, National Institutes of Health 2009."},{"key":"4404_CR42","unstructured":"Institute NC. NCI guidelines for investigators: adverse event reporting requirements for DCTD (CTEP and CIP) and DCP INDs and ides. National Cancer Institute Bethesda, MD 2013."},{"issue":"5","key":"4404_CR43","first-page":"89","volume":"9","author":"AK Sharma","year":"2020","unstructured":"Sharma AK, Gokulchandran N, Kulkarni PP, Sane HM, Sharma R, Jose A, et al. Cell transplantation as a novel therapeutic strategy for autism spectrum disorders: a clinical study. Am J Stem Cells. 2020;9(5):89.","journal-title":"Am J Stem Cells"},{"issue":"1","key":"4404_CR44","first-page":"905874","volume":"2015","author":"A Sharma","year":"2015","unstructured":"Sharma A, Sane H, Gokulchandran N, Kulkarni P, Gandhi S, Sundaram J, et al. A clinical study of autologous bone marrow mononuclear cells for cerebral palsy patients: a new frontier. Stem Cells Int. 2015;2015(1):905874.","journal-title":"Stem Cells Int"},{"key":"4404_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12887-017-0859-z","volume":"17","author":"LT Nguyen","year":"2017","unstructured":"Nguyen LT, Nguyen AT, Vu CD, Ngo DV, Bui AV. Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial. BMC Pediatr. 2017;17:1\u20136.","journal-title":"BMC Pediatr"},{"key":"4404_CR46","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fimmu.2012.00297","volume":"3","author":"E Eggenhofer","year":"2012","unstructured":"Eggenhofer E, Benseler V, Kroemer A, Popp F, Geissler E, Schlitt H, et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol. 2012;3:297.","journal-title":"Front Immunol"},{"issue":"4\u20136","key":"4404_CR47","first-page":"78","volume":"19","author":"L Villarreal-Martinez","year":"2022","unstructured":"Villarreal-Martinez L, Mart\u00cdnez-Garza LE, Rodriguez-Sanchez IP, Alvarez-Villalobos N, Guzman-Gallardo F, Pope-Salazar S, et al. Correlation between CD133\u2009+\u2009Stem cells and clinical improvement in patients with autism spectrum disorders treated with intrathecal bone Marrow-derived mononuclear cells. Innovations Clin Neurosci. 2022;19(4\u20136):78.","journal-title":"Innovations Clin Neurosci"},{"issue":"4","key":"4404_CR48","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/sctm.17-0042","volume":"7","author":"M Chez","year":"2018","unstructured":"Chez M, Lepage C, Parise C, Dang-Chu A, Hankins A, Carroll M. Safety and observations from a placebo-controlled, crossover study to assess use of autologous umbilical cord blood stem cells to improve symptoms in children with autism. Stem Cells Translational Med. 2018;7(4):333\u201341.","journal-title":"Stem Cells Translational Med"},{"issue":"7","key":"4404_CR49","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1007\/s10571-023-01377-x","volume":"43","author":"QT Nguyen","year":"2023","unstructured":"Nguyen QT, Thanh LN, Hoang VT, Phan TT, Heke M, Hoang DM. Bone Marrow-Derived mononuclear cells in the treatment of neurological diseases: knowns and unknowns. Cell Mol Neurobiol. 2023;43(7):3211\u201350.","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"4404_CR50","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1172\/JCI200420622","volume":"114","author":"A Taguchi","year":"2004","unstructured":"Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H, et al. Administration of CD34\u2009+\u2009cells after stroke enhances neurogenesis via angiogenesisin a mouse model. J Clin Investig. 2004;114(3):330\u20138.","journal-title":"J Clin Investig"},{"issue":"17","key":"4404_CR51","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.3390\/cells12172162","volume":"12","author":"F Mohamad Yusoff","year":"2023","unstructured":"Mohamad Yusoff F, Higashi Y. Mesenchymal stem\/stromal cells for therapeutic angiogenesis. Cells. 2023;12(17):2162.","journal-title":"Cells"},{"issue":"16","key":"4404_CR52","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1042\/CS20180360","volume":"132","author":"C Peng","year":"2018","unstructured":"Peng C, Dong X-H, Liu J-L, Tao Y-L, Xu C-F, Wang L-P, et al. A preventive injection of endothelial progenitor cells prolongs lifespan in stroke-prone spontaneously hypertensive rats. Clin Sci. 2018;132(16):1797\u2013810.","journal-title":"Clin Sci"},{"issue":"6","key":"4404_CR53","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1161\/STROKEAHA.116.012701","volume":"47","author":"FS Vahidy","year":"2016","unstructured":"Vahidy FS, Rahbar MH, Zhu H, Rowan PJ, Bambhroliya AB, Savitz SI. Systematic review and meta-analysis of bone marrow\u2013derived mononuclear cells in animal models of ischemic stroke. Stroke. 2016;47(6):1632\u20139.","journal-title":"Stroke"},{"issue":"4","key":"4404_CR54","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s12975-016-0462-x","volume":"7","author":"B Yang","year":"2016","unstructured":"Yang B, Parsha K, Schaar K, Xi X, Aronowski J, Savitz SI. Various cell populations within the mononuclear fraction of bone marrow contribute to the beneficial effects of autologous bone marrow cell therapy in a rodent stroke model. Translational Stroke Res. 2016;7(4):322\u201330.","journal-title":"Translational Stroke Res"},{"issue":"20","key":"4404_CR55","doi-asserted-by":"publisher","first-page":"15080","DOI":"10.3390\/ijms242015080","volume":"24","author":"DM Maric","year":"2023","unstructured":"Maric DM, Vojvodic D, Maric DL, Velikic G, Radomir M, Sokolovac I, et al. Cytokine dynamics in autism: analysis of BMAC therapy outcomes. Int J Mol Sci. 2023;24(20):15080.","journal-title":"Int J Mol Sci"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04404-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04404-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04404-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T02:02:45Z","timestamp":1748570565000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04404-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4404"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04404-4","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the National Ethics Committee of the Vietnam Ministry of Health, with approval number 120\/CN-HDDD. Title of the approved project: \u201cAutologous Bone Marrow Mononuclear Cell Transplantation Combined with Educational Intervention for Autism Spectrum Disorders (ASD): A Phase II Randomized Controlled Trial\u201d; Name of the institutional approval committee: The National Ethics Committee of the Vietnam Ministry of Health (Hanoi, Vietnam); Approval number: 120\/CN-HDDD; Date of approval: November 05, 2021. The patients\u2019 guardians or legally authorized representatives provided written informed consent for their participation in the study and the use of samples. The consent explicitly included permission to use patient identifiers, such as age and sex, for publication purposes. All treatments, including clinical examinations, laboratory tests, brain MRI, EEG, genetic tests, cell collection, cell processing, cell administration, hospital stay fees, and educational interventions, were provided free of charge to the participants and their families.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"268"}}